SEC Form 4 · accession 0001209191-18-045615
TEVA PHARMACEUTICAL INDUSTRIES LTD · TEVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sven Dethlefs
Officer — EVP Global Marketing&Portfolio
Period of report
Aug 3, 2018
Accepted (ET)
Aug 7, 2018 · 9:45 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000818686
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 3, 2018 | P | 2,000 | $21.92 | A | 6,445 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.